Abstract 1770: Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakR, Displays Broad Anticancer Activity Which is Dependent on NFκB SignalingJames Purcell,Sonia Tanlimco,Minhtam Doan,Peter Lambert,Keith Wilson,Gary Starling,Patricia Culp,Han KimCancer research（2011）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
